CORRECTION article

Front. Mol. Biosci., 30 August 2021

Sec. Molecular Diagnostics and Therapeutics

Volume 8 - 2021 | https://doi.org/10.3389/fmolb.2021.727347

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

    ZW

    Zongxia Wang 1

    LJ

    Lizhou Jia 1,2

    YS

    Yushu sun 3

    CL

    Chunli Li 1

    LZ

    Lingli Zhang 4

    XW

    Xiangcheng Wang 5,6*

    HC

    Hao Chen 2,7*

  • 1. Cancer Center, Bayannur Hospital, Bayannur, China

  • 2. Department of Pathology, Wannan Medical College, Wuhu, China

  • 3. Department of Oncology, Inner Mongolia Autonomous Region Cancer Hospital, Hohhot, China

  • 4. Department of Ophthalmology, Inner Mongolia Autonomous Region People’s Hospital, Hohhot, China

  • 5. Department of Nuclear Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China

  • 6. Key Laboratory of Inner Mongolia Autonomous Region Molecular Imaging, Inner Mongolia Medical University, Hohhot, China

  • 7. Faculty of Medical Science, Jinan University, Guangzhou, China

Article metrics

View details

1,2k

Views

504

Downloads

In the original article, there was a mistake in the caption for

Figure 4A

as published. The incorrect caption stated NCM460 cell lines are normal gastric epithelial cells, however, NCM460 cell lines are normal colorectal epithelial cells. The correct caption for

Figure 4

appears below. Additionally, there was a mistake in

Figure 1

as published. Figure 1C is immunofluorescence and

Figure 1D

is immunocomplex by Co-IP. OE-ControlTrop2 should appear on the top row and OE-Trop2 should appear on the bottom row in

Figure 1C

. Representative images for these parts contain small issues which have been corrected. The corrected

Figure 1

appears below.

  • FIGURE 4. The effects of CORO1C knockdown on CRC growth and metastasis in vitro and in vivo. (A) Levels of CORO1C1 protein expression in CRC cell lines and normal colorectal epithelial cells (NCM460) determined by western blotting. (B) COCA2 and HCT116 cells showed a significant decrease in protein level after shCORO1C transfection. (C) CORO1C downregulation significantly inhibited the proliferation of both cell lines. (D) A significant decrease in cell anchorage-dependent growth was detected after CORO1C knockdown. (E, F) Decreased CORO1C expression impaired abilities of migration (E) and invasion (F) of CRC cells (scale bar, 150 μm). All quantitative data of invitro assays were generated from three replicates (G). The effects of CORO1C downregulation on the tumor growth in the xenograft mouse model (n = 6 mice/per group). *p < 0.05, **p < 0.01, ***p < 0.001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

FIGURE 1

FIGURE 1

Associations between CORO1C, TROP2, and CRC metastasis. Overexpression of Trop2 in 293T cells was confirmed by (A) qRT-PCR, (B) Western blotting, and (C) Immunofluorescence. (D) Trop2 immunocomplex by Co-IP; (E) Heatmap of proteins interacting with Trop2 in PC and MC. The RNA-seq data were obtained from GSE28702. Red and green colors represent high and low gene expression, respectively. PC: primary CRC; MC: metastatic CRC, **p < 0.01.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

CORO1C, colorectal cancer, prognosis, metastasis, Akt

Citation

Wang Z, Jia L, Yushu sun, Li C, Zhang L, Wang X and Chen H (2021) Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer. Front. Mol. Biosci. 8:727347. doi: 10.3389/fmolb.2021.727347

Received

18 June 2021

Accepted

14 July 2021

Published

30 August 2021

Volume

8 - 2021

Edited by

Haishi Qiao, China Pharmaceutical University, China

Reviewed by

Ern Yu Tan, Tan Tock Seng Hospital, Singapore

Updates

Copyright

*Correspondence: Xiangcheng Wang, ; Hao Chen,

This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics